Abzena has acquired 2 companies of its own.
Abzena’s largest acquisition to date was in 2015, when it acquired PacificGMP for $8M. Abzena has acquired in 2 different US states. The Company’s most targeted sectors include life science (50%) and medical products (50%).
Babraham Research Campus, Babraham,
Cambridge,
CB22 3AT
United Kingdom,
+44 1223 903 498
www.abzena.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2015-12-11 |
The Chemistry Research Solution LLC · Life Science
Bristol, Pennsylvania · www.tcrs.us The Chemistry Research Solution LLC is a contract chemistry and bioconjugation business focused on antibody drug conjugates (ADCs). |
- | Add-on Acquisition | - |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
